Skip to main content
Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
31.98
+2.64 (9.00%)
Apr 29, 2026, 4:08 PM HKT

HKG:3378 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
 CurrentFY 2025 FY 2024 FY 2023
Period Ending
 Apr '26 Dec '25 Dec '24 Dec '23
Market Capitalization
4,3562,177--
Enterprise Value
3,7482,106--
Last Close Price
31.9815.98--
PS Ratio
42550.5121262.04--
PB Ratio
5.242.62--
P/TBV Ratio
5.612.81--
EV/Sales Ratio
-20565.97--
Debt / Equity Ratio
0.080.080.060.05
Net Debt / Equity Ratio
-0.80-0.80-0.75-0.59
Net Debt / EBITDA Ratio
4.174.171.393.11
Net Debt / FCF Ratio
--1.463.37
Asset Turnover
000.00-
Quick Ratio
6.866.860.883.25
Current Ratio
7.277.271.234.75
Return on Equity (ROE)
-27.27%-27.27%-43.61%-
Return on Assets (ROA)
-12.63%-12.63%-13.64%-
Return on Capital Employed (ROCE)
-17.30%-17.30%-39.00%-11.70%
Earnings Yield
-3.35%-6.70%--
Buyback Yield / Dilution
--982.20%-49.83%-
Source: S&P Capital IQ. Standard template. Financial Sources.